Medimi AB reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 0.578 million compared to SEK 0.333 million a year ago. Revenue was SEK 0.578 million compared to SEK 1.05 million a year ago.

Net loss was SEK 4.31 million compared to SEK 4.37 million a year ago. Basic loss per share from continuing operations was SEK 0.01 compared to SEK 0.02 a year ago. Diluted loss per share from continuing operations was SEK 0.01 compared to SEK 0.02 a year ago.